BELLUS Health Inc.
BLU
Cena:
Valuace
100
Růst
30
Zdraví
52
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
0
BELLUS HEALTH INC. ANNOUNCES VOTING RESULTS FROM SPECIAL MEETING OF SHAREHOLDERS
16-06-2023
MONTREAL--(BUSINESS WIRE)--BELLUS HEALTH INC. (NASDAQ: BLU; TSX: BLU.TO) (“BELLUS” OR THE “COM...
Více zde
ALLIANCE ENTERTAINMENT REPORTS THIRD QUARTER AND NINE MONTH FISCAL 2023 FINANCIAL RESULTS
22-05-2023
PLANTATION, FLA.--(BUSINESS WIRE)--ALLIANCE ENTERTAINMENT HOLDING CORPORATION (OTC: AENT) (“ALLIAN...
Více zde
BELLUS HEALTH INC. CALLS SPECIAL SHAREHOLDERS' MEETING IN CONNECTION WITH GSK ACQUISITION
16-05-2023
MONTREAL--(BUSINESS WIRE)--BELLUS HEALTH INC. (NASDAQ: BLU; TSX: BLU.TO) (“BELLUS” OR THE “COM...
Více zde
BELLUS SANTÉ ANNONCE SES RÉSULTATS FINANCIERS ET FAITS SAILLANTS POUR LE PREMIER TRIMESTRE DE 2023
12-05-2023
LAVAL, QUÉBEC--(BUSINESS WIRE)--BELLUS SANTÉ INC. (NASDAQ : BLU; TSX : BLU) (« BELLUS SANTÉ » O...
Více zde
TOMMY HILFIGER, MERCEDES-AMG PETRONAS FORMULA ONE TEAM E AWAKE NY LANCIANO UNA COLLABORAZIONE AL GRAND PRIX DI MIAMI
04-05-2023
AMSTERDAM--(BUSINESS WIRE)--TOMMY HILFIGER, MARCHIO DI PROPRIETÀ DI PVH CORP. [NYSE: PVH], ANNUNCIA...
Více zde
CRACKLE CONNEX SHOWCASES ITS UNIQUE ADVERTISING AND MEDIA OFFERING AT IAB NEWFRONTS
03-05-2023
NEW YORK--(BUSINESS WIRE)--CRACKLE CONNEX, CHICKEN SOUP FOR THE SOUL ENTERTAINMENT’S (NASDAQ: CSSE...
Více zde
THE ST. JOE COMPANY ANNOUNCES THE OPENING OF THE 255-SUITE EMBASSY SUITES BY HILTON PANAMA CITY BEACH RESORT
27-04-2023
PANAMA CITY BEACH, FLA.--(BUSINESS WIRE)--THE ST. JOE COMPANY (NYSE: JOE) (“ST. JOE”), JOINT VEN...
Více zde
BELLUS SANTÉ ANNONCE DE L’INFORMATION RÉCENTE AU SUJET DE L’ASSEMBLÉE
26-04-2023
LAVAL, QUÉBEC--(BUSINESS WIRE)--BELLUS SANTÉ INC. (NASDAQ : BLU; TSX : BLU) (« BELLUS SANTÉ » O...
Více zde
GSK REACHES AGREEMENT TO ACQUIRE LATE-STAGE BIOPHARMACEUTICAL COMPANY BELLUS HEALTH
18-04-2023
LONDON--(BUSINESS WIRE)--GSK PLC (LSE/NYSE: GSK) AND BELLUS HEALTH INC. (TSX/NASDAQ: BLU) TODAY ANNO...
Více zde
BELLUS HEALTH ANNOUNCES POSITIVE RESULTS FROM ITS PHASE 1 BIOAVAILABILITY EQUIVALENCE STUDY EVALUATING ONCE-DAILY EXTENDED-RELEASE FORMULATION OF CAMLIPIXANT IN COMPARISON TO TWICE-DAILY IMMEDIATE RELEASE FORMULATION
05-04-2023
LAVAL, QUEBEC--(BUSINESS WIRE)--BELLUS HEALTH INC....
Více zde
BELLUS HEALTH REPORTS YEAR 2022 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
21-03-2023
LAVAL, QUEBEC--(BUSINESS WIRE)--BELLUS HEALTH INC. (NASDAQ:BLU; TSX:BLU) (“BELLUS HEALTH” OR THE...
Více zde
BELLUS HEALTH TO PARTICIPATE IN THE COWEN 43RD ANNUAL HEALTH CARE CONFERENCE
01-03-2023
LAVAL, QUEBEC--(BUSINESS WIRE)--BELLUS HEALTH INC....
Více zde
BELLUS HEALTH REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
14-11-2022
LAVAL, QUEBEC--( BUSINESS WIRE )--BELLUS HEALTH INC. (NASDAQ:BLU; TSX:BLU) (“BELLUS HEALTH” OR T...
Více zde
BELLUS HEALTH TO PRESENT CLINICAL DATA FROM PHASE 2B SOOTHE TRIAL OF BLU-5937 AT THE CHEST ANNUAL MEETING
10-10-2022
LAVAL, QUEBEC--(BUSINESS WIRE)--BELLUS HEALTH INC. (NASDAQ:BLU; TSX:BLU) (“BELLUS HEALTH” OR THE...
Více zde
BELLUS HEALTH TO PRESENT CLINICAL DATA FROM PHASE 2B SOOTHE TRIAL OF BLU-5937 AT THE EUROPEAN RESPIRATORY SOCIETY INTERNATIONAL CONGRESS 2022
22-08-2022
LAVAL, QUEBEC--(BUSINESS WIRE)--BELLUS HEALTH INC. (NASDAQ:BLU; TSX:BLU) (“BELLUS HEALTH” OR THE...
Více zde
BELLUS HEALTH REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
10-08-2022
LAVAL, QUEBEC--(BUSINESS WIRE)--BELLUS HEALTH INC. (NASDAQ:BLU; TSX:BLU) (“BELLUS HEALTH” OR THE...
Více zde
BELLUS HEALTH CLOSES US$153 MILLION PUBLIC OFFERING OF COMMON SHARES IN CANADA AND THE UNITED STATES
18-07-2022
LAVAL, QUEBEC--(BUSINESS WIRE)--BELLUS HEALTH INC. (NASDAQ: BLU)(TSX: BLU) (THE “COMPANY” OR “...
Více zde
BELLUS HEALTH ANNOUNCES PRICING OF US$153 MILLION PUBLIC OFFERING IN CANADA AND THE UNITED STATES
13-07-2022
LAVAL, QUEBEC--(BUSINESS WIRE)--IN CONNECTION WITH ITS PREVIOUSLY ANNOUNCED PUBLIC OFFERING OF COMMO...
Více zde
BELLUS HEALTH ANNOUNCES THE LAUNCH OF A PUBLIC OFFERING OF COMMON SHARES IN CANADA AND THE UNITED STATES
13-07-2022
LAVAL, QUEBEC--(BUSINESS WIRE)--BELLUS HEALTH INC. (“BELLUS HEALTH” OR THE “COMPANY”) (TSX A...
Více zde
BELLUS HEALTH ANNOUNCES POSITIVE END-OF-PHASE 2 MEETING WITH THE FDA AND ITS CALM PHASE 3 PROGRAM FOR BLU-5937 IN REFRACTORY CHRONIC COUGH
12-07-2022
LAVAL, QUEBEC--(BUSINESS WIRE)--BELLUS HEALTH INC. (NASDAQ: BLU; TSX: BLU) (“BELLUS HEALTH” OR T...
Více zde
BELLUS HEALTH TO PARTICIPATE IN THE WILLIAM BLAIR BIOTECH FOCUS CONFERENCE
05-07-2022
LAVAL, QUEBEC--(BUSINESS WIRE)--BELLUS HEALTH INC. (NASDAQ:BLU; TSX:BLU) (“BELLUS HEALTH” OR THE...
Více zde
BELLUS HEALTH TO PARTICIPATE IN THE JEFFERIES HEALTHCARE CONFERENCE
01-06-2022
LAVAL, QUEBEC--(BUSINESS WIRE)--BELLUS HEALTH INC. (NASDAQ:BLU; TSX:BLU) (“BELLUS HEALTH” OR THE...
Více zde
BELLUS HEALTH REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
11-05-2022
LAVAL, QUEBEC--(BUSINESS WIRE)--BELLUS HEALTH INC. (NASDAQ: BLU; TSX: BLU) (“BELLUS HEALTH” OR T...
Více zde
BELLUS HEALTH TO PARTICIPATE IN THE COWEN & CO. 42ND ANNUAL HEALTH CARE CONFERENCE
01-03-2022
LAVAL, QUEBEC--(BUSINESS WIRE)--BELLUS HEALTH INC. (NASDAQ:BLU; TSX:BLU) (“BELLUS HEALTH” OR THE...
Více zde
BELLUS HEALTH REPORTS YEAR 2021 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
23-02-2022
LAVAL, QUEBEC--(BUSINESS WIRE)--BELLUS HEALTH INC. (NASDAQ:BLU; TSX:BLU) (“BELLUS HEALTH” OR THE...
Více zde
BELLUS HEALTH CLOSES US$200 MILLION PUBLIC OFFERING OF COMMON SHARES IN CANADA AND THE UNITED STATES
17-12-2021
LAVAL, QUEBEC--(BUSINESS WIRE)--BELLUS HEALTH INC. (NASDAQ: BLU)(TSX: BLU) (THE “COMPANY” OR “...
Více zde
BELLUS HEALTH ANNOUNCES PRICING OF US$200 MILLION PUBLIC OFFERING IN CANADA AND THE UNITED STATES
14-12-2021
LAVAL, QUEBEC--(BUSINESS WIRE)--IN CONNECTION WITH ITS PREVIOUSLY ANNOUNCED PUBLIC OFFERING OF COMMO...
Více zde
BELLUS HEALTH ANNOUNCES POSITIVE TOPLINE RESULTS FROM ITS PHASE 2B SOOTHE TRIAL OF BLU-5937 FOR THE TREATMENT OF REFRACTORY CHRONIC COUGH
13-12-2021
LAVAL, QUEBEC--(BUSINESS WIRE)--BELLUS HEALTH INC. (NASDAQ:BLU; TSX:BLU) (“BELLUS HEALTH” OR THE...
Více zde
BELLUS HEALTH REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
10-11-2021
LAVAL, QUEBEC--(BUSINESS WIRE)--BELLUS HEALTH INC. (NASDAQ:BLU; TSX:BLU) (“BELLUS HEALTH” OR THE...
Více zde
BELLUS HEALTH ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN SOOTHE PHASE 2B TRIAL FOR REFRACTORY CHRONIC COUGH AND BLUEPRINT PHASE 2A TRIAL FOR CHRONIC PRURITUS ASSOCIATED WITH ATOPIC DERMATITIS
23-09-2021
LAVAL, QUEBEC--(BUSINESS WIRE)--BELLUS HEALTH INC. (NASDAQ:BLU; TSX:BLU) (“BELLUS HEALTH” OR THE...
Více zde
Dokumenty nejsou k dispozici
